CHST11 and prostate cancer: However, pre-cell death assessment of CSA expression at 48 h after CHST11 knockdown (Fig. 4h), showed a significant reduction of CSA chains in PC-3 cells (Fig. 4i), supporting the idea that CHST11 is driving CSA expression in prostate cancer.